Speaker illustration

Doctor Jocelyn Inamo

University Hospital of Fort de France, Fort de France (Martinique)

Member of:

European Society of Cardiology

Demographic characteristics and clinical follow-up of the 2788 transthyretin amyloid cardiomyopathy patients treated with tafamidis during the French Early Access Program (RTU)

Event: Heart Failure 2023

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Cardiac amyloidosis from epidemiology to treatment


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb